Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF: Sanchez BC, Sundqvist M, Fohlin H, et al (Karolinska Inst and Univ Hosp, Stockholm, Sweden; Kalmar Hosp, Sweden; Univ Hosp, Linköping, Sweden; et al) Eur J Cancer 46:1580-1587, 2010§